The Health Care M&A Monthly:O La La: Sanofi Launches Hostile Bid for Aventis Worth $61 Billion
The Players Sanofi-Synthélabo took shape under the leadership of CEO Jean-François Dehecq. In the late 1960s, M. Dehecq joined the French oil company Elf Aquitaine, SA. As part of a move to diversify its chemicals business, in 1973 the company enlisted M. Dehecq to...The Health Care M&A Monthly: WellPoint Buys RightChoice Managed Care For $1.3 Billion
Does the largest health care transaction of the month signal a renaissance in the Managed Care M&A market, or is it just a fluke? In late October, WellPoint Health Networks, Inc. (NYSE: WLP) announced that it would acquire RightChoice Managed Care, Inc. (NYSE:...The Health Care M&A Monthly: Biotech Companies Go on A Holiday Shopping Spree
During the past month, M&A activity has moved at a brisk trot in the biopharmaceutical industry. Between them, the Biotechnology and Pharmaceutical sectors have posted 17 deals, better than one every other day. The combined value of these deals is impressive,...The Health Care M&A Monthly: Health Care M&A Results for The Third Quarter of 2001
A total of 174 mergers and acquisitions were announced in the health care industry during the third quarter of 2001, down 16% from the previous quarter’s 208 deals. The chart below tallies the deals by sector. The September 11 attacks on New York and Washington, along...The Health Care M&A Monthly: How Will the Market Respond in the Wake of Terrorism?
The sights and sounds of September 11, 2001 will stay burned into our minds for some time to come. On that black Tuesday, much of the country’s financial activity was suspended: the major stock exchanges closed and the M&A market ground to a virtual standstill....Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
